- Home
- CLDX vs ACDC Comparison
CLDX vs ACDC Comparison
Compare CLDX & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- ACDC
- Stock Information
- Founded
- CLDX N/A
- ACDC 2014
- Country
- CLDX United States
- ACDC United States
- Employees
- CLDX N/A
- ACDC N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ACDC Oilfield Services/Equipment
- Sector
- CLDX Health Care
- ACDC Energy
- Exchange
- CLDX Nasdaq
- ACDC Nasdaq
- Market Cap
- CLDX 1.3B
- ACDC 1.1B
- IPO Year
- CLDX 2008
- ACDC 2022
- Fundamental
- Price
- CLDX $16.85
- ACDC $7.97
- Analyst Decision
- CLDX Buy
- ACDC Hold
- Analyst Count
- CLDX 8
- ACDC 5
- Target Price
- CLDX $54.29
- ACDC $7.60
- AVG Volume (30 Days)
- CLDX 767.1K
- ACDC 497.2K
- Earning Date
- CLDX 05-05-2025
- ACDC 03-06-2025
- Dividend Yield
- CLDX N/A
- ACDC N/A
- EPS Growth
- CLDX N/A
- ACDC N/A
- EPS
- CLDX N/A
- ACDC N/A
- Revenue
- CLDX $7,020,000.00
- ACDC $2,190,900,000.00
- Revenue This Year
- CLDX N/A
- ACDC N/A
- Revenue Next Year
- CLDX $27.01
- ACDC $12.88
- P/E Ratio
- CLDX N/A
- ACDC N/A
- Revenue Growth
- CLDX 1.99
- ACDC N/A
- 52 Week Low
- CLDX $16.75
- ACDC $5.16
- 52 Week High
- CLDX $47.00
- ACDC $9.75
- Technical
- Relative Strength Index (RSI)
- CLDX 29.79
- ACDC 49.73
- Support Level
- CLDX $19.48
- ACDC $6.90
- Resistance Level
- CLDX $20.38
- ACDC $8.29
- Average True Range (ATR)
- CLDX 1.03
- ACDC 0.40
- MACD
- CLDX -0.17
- ACDC 0.03
- Stochastic Oscillator
- CLDX 2.19
- ACDC 45.13
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.